Sign In
Buy OGN
$13.56
+0 (+0%)
At Close: Aug 04, 2026
Orogen Royalties Reports Continued Exploration Success on Ermitaño Royalty AOI
07:30am, Thursday, 18'th Dec 2025
VANCOUVER, BC / ACCESS Newswire / December 18, 2025 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce an exploration update on the Ermitaño gold mine
Is Trending Stock Organon & Co. (OGN) a Buy Now?
10:00am, Friday, 12'th Dec 2025
Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Orogen Royalties Notes Initial Resource Estimate on Kodiak Copper's MPD Copper-Gold Project
07:30am, Thursday, 11'th Dec 2025
VANCOUVER, BC / ACCESS Newswire / December 11, 2025 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to note Kodiak Copper Corp.'s (TSX.V:KDK) ("Kodiak") announce
Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
12:23pm, Wednesday, 03'rd Dec 2025
Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Organon & Co. $OGN Shares Acquired by Brandes Investment Partners LP
04:36am, Wednesday, 03'rd Dec 2025
Brandes Investment Partners LP grew its stake in Organon and Co. (NYSE: OGN) by 77.1% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 398,423 shares of
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
10:01am, Monday, 01'st Dec 2025
Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Creative Planning Buys 97,429 Shares of Organon & Co. $OGN
04:03am, Thursday, 27'th Nov 2025
Creative Planning grew its stake in shares of Organon and Co. (NYSE: OGN) by 109.2% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange C
Organon To Present at the Piper Sandler 37th Annual Healthcare Conference
07:30am, Tuesday, 25'th Nov 2025
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon's Interim CEO Joe Morrissey and CFO Matthew Walsh to participate in fireside chat at Piper Sandler Annual Healthcare Conference on December 3.
Orogen Posts Profitable Financial Results and Cash Flow Strength in Q3-2025
07:30am, Tuesday, 25'th Nov 2025
VANCOUVER, BC / ACCESS Newswire / November 25, 2025 / (TSXV:OGN)(OTC:OGNNF) Orogen Royalties Inc. (formerly 1537944 BC Ltd.) ("Orogen" or the "Company") is pleased to announce robust profitability and
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
10:02am, Tuesday, 18'th Nov 2025
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
05:30am, Monday, 17'th Nov 2025
SHANGHAI & JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon and Henlius announce FDA approval of POHERDY, the first and only pertuzumab biosimilar in the US, which is interchangeable to Perjeta.
Kahn Brothers' Strategic Moves: GSK PLC Sees a -3.08% Impact
12:00pm, Wednesday, 12'th Nov 2025
Exploring Kahn Brothers (Trades, Portfolio)' Recent 13F Filing and Investment Strategies Kahn Brothers (Trades, Portfolio) recently submitted their 13F filing
Organon: Q3 Earnings Lift Struggling Stock - But Not For Long, I Suspect
12:58pm, Tuesday, 11'th Nov 2025
Organon & Co. faces ongoing challenges, with shares down over 75% since debut and recent CEO resignation after inventory probe. OGN Q3 results show stagnant revenues, declining Women's Health sales, a
Organon Analysts Cut Their Forecasts Following Q3 Results
11:40am, Tuesday, 11'th Nov 2025
Organon (NYSE:OGN) reported better-than-expected earnings for the third quarter on Monday.
Organon (OGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
02:36pm, Monday, 10'th Nov 2025
Although the revenue and EPS for Organon (OGN) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Stre
